News

ProteinQure Strengthens Leadership Team with Key Appointments to Accelerate Translational and Clinical Development Programs

ProteinQure – Dare to Deliver

ProteinQure Announces A Breakthrough Therapeutic with Remarkable Efficacy in Heterogenous Patient-Derived Xenograft Models of Triple-Negative Breast Cancer to be presented at AACR

Peptide binders for all

Differences in breast cancer through a biochemical lens

ProteinQure’s Recent Breakthrough: A ‘Smart’ Breast Cancer Drug

ProteinQure Inc. Announces Robust Preclinical Efficacy in a Triple Negative Breast Cancer Mouse Tumour Model Study

AlphaFold Quickstart on AWS

ProteinQure Collaborates with AstraZeneca to Design Novel Peptide Therapeutics

ProteinQure raises $4M seed round to unlock the potential of protein therapeutics

Welcome into the fold

Designing a healthier tomorrow